webleads-tracker

Home  >  MEDTECH  > Canada’s GenePOC eyes 2014 for Point-of-Care MDx System, ...
  >  MEDTECH
Nov 14th, 2012
 
Canada’s GenePOC eyes 2014 for Point-of-Care MDx System, Group B Strep Test
 
CANADIAN MOLECULAR DIAGNOSTICS firm Gene- POC has completed technical development of its benchtop, point-of-care molecular diagnostic system and disposable test cartridges, and has commenced clinical feasibility studies of the platform, company executives said this week
Send to a friend

In addition, the company hopes to begin clinical trials for its first commercial assay – a molecular test to detect group B streptococcus in pregnant women – by the end of 2013, with the hopes of launching the assay and its system, called GenePOC Diagnostics, by the end of 2014.

Reprinted with permission of GenePOC

 


 
More MEDTECH news

Apr 11th
Apr 9th
Apr 7th
Apr 7th
Apr 3rd
 
©2007 Yole Developpement All rights reserved                  Disclaimer | Legal notice | To advertise
Yole Développement: Le Quartz, 75 cours Emile Zola, 69100 Villeurbanne, France. TEL: (33) 472 83 01 80 FAX: (33) 472 83 01 83 E-Mail: info @yole.fr